{"DataElement":{"publicId":"8123026","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Classification Type","preferredDefinition":"The term refers to precursor lymphoid neoplasms which are composed of B-lymphoblasts and characterized by the presence of recurrent genetic abnormalities.","longName":"ALL_RP_GENE_ABN","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"8123015","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Classification","preferredDefinition":"The term refers to precursor lymphoid neoplasms which are composed of B-lymphoblasts and characterized by the presence of recurrent genetic abnormalities._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"8123013v1.0:2321361v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"8123013","version":"1","preferredName":"B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities","preferredDefinition":"The term refers to precursor lymphoid neoplasms which are composed of B-lymphoblasts and characterized by the presence of recurrent genetic abnormalities.","longName":"C80328","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"B Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities","conceptCode":"C80328","definition":"B-lymphoblastic leukemias/lymphomas characterized by the presence of recurring cytogenetic and/or molecular abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49F4EB-0ECF-6D69-E053-4EBD850A25D4","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49F4EB-0EDD-6D69-E053-4EBD850A25D4","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"LEEW","dateModified":"2022-04-07","changeDescription":"WL - APAL2020B","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"8123016","version":"1","preferredName":"Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"8123016v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"B-lymphoblastic leukemia/lymphoma with iAMP21","valueDescription":"B-lymphoblastic leukemia/lymphoma with iAMP21","ValueMeaning":{"publicId":"8123017","version":"1","preferredName":"B-lymphoblastic leukemia/lymphoma with iAMP21","longName":"8123017","preferredDefinition":"B-lymphoblastic leukemia/lymphoma with iAMP21","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D205-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB49B2EB-D21E-6D67-E053-4EBD850A78FF","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia/lymphoma, BCR-ABL1-like","valueDescription":"B-lymphoblastic leukemia/lymphoma, BCR-ABL1Â–like","ValueMeaning":{"publicId":"8123018","version":"1","preferredName":"B-lymphoblastic leukemia/lymphoma, BCR-ABL1-like","longName":"8123018v1.00","preferredDefinition":"B-lymphoblastic leukemia/lymphoma, BCR-ABL1-like","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D228-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB49B2EB-D241-6D67-E053-4EBD850A78FF","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-18","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1","valueDescription":"B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1","ValueMeaning":{"publicId":"8123019","version":"1","preferredName":"B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1","longName":"8123019","preferredDefinition":"B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D24B-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB49B2EB-D264-6D67-E053-4EBD850A78FF","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH","valueDescription":"B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH","ValueMeaning":{"publicId":"8123020","version":"1","preferredName":"B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH","longName":"8123020","preferredDefinition":"B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D26E-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB49B2EB-D287-6D67-E053-4EBD850A78FF","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia/lymphoma with hypodiploidy","valueDescription":"B-lymphoblastic leukemia/lymphoma with hypodiploidy","ValueMeaning":{"publicId":"8123021","version":"1","preferredName":"B-lymphoblastic leukemia/lymphoma with hypodiploidy","longName":"8123021","preferredDefinition":"B-lymphoblastic leukemia/lymphoma with hypodiploidy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D291-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB49B2EB-D2AA-6D67-E053-4EBD850A78FF","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia/lymphoma with hyperdiploidy","valueDescription":"B-lymphoblastic leukemia/lymphoma with hyperdiploidy","ValueMeaning":{"publicId":"8123022","version":"1","preferredName":"B-lymphoblastic leukemia/lymphoma with hyperdiploidy","longName":"8123022","preferredDefinition":"B-lymphoblastic leukemia/lymphoma with hyperdiploidy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D2B4-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB49B2EB-D2CD-6D67-E053-4EBD850A78FF","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1","valueDescription":"B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1","ValueMeaning":{"publicId":"8123023","version":"1","preferredName":"B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1","longName":"8123023","preferredDefinition":"B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D2D7-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB49B2EB-D2F0-6D67-E053-4EBD850A78FF","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia/lymphoma with t(v;11q23.3);KMT2A rearranged","valueDescription":"B-lymphoblastic leukemia/lymphoma with t(v;11q23.3);KMT2A rearranged","ValueMeaning":{"publicId":"8123024","version":"1","preferredName":"B-lymphoblastic leukemia/lymphoma with t(v;11q23.3);KMT2A rearranged","longName":"8123024","preferredDefinition":"B-lymphoblastic leukemia/lymphoma with t(v;11q23.3);KMT2A rearranged","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D2FA-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB49B2EB-D313-6D67-E053-4EBD850A78FF","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"},{"value":"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1","valueDescription":"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1","ValueMeaning":{"publicId":"8123025","version":"1","preferredName":"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1","longName":"8123025","preferredDefinition":"B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D31D-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB49B2EB-D336-6D67-E053-4EBD850A78FF","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"ONEDATA","dateModified":"2022-03-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D1F0-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"KUMMEROA","dateModified":"2022-11-18","changeDescription":"WL - APAL2020B","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"B-lymphoblastic leukemia/lymp","type":"Preferred Question Text","description":"B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB49B2EB-D346-6D67-E053-4EBD850A78FF","latestVersionIndicator":"Yes","beginDate":"2022-03-28","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-28","modifiedBy":"LEEW","dateModified":"2022-04-07","changeDescription":"WL - APAL2020B","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}